Venture Capital Panel Focuses on Exit Strategies at Medtech Insight and Windhover Information's ``In3 Medical Device Summit'' - The Largest Strategic Partnership and Investment Meeting for Medical Technology Executives.

NORWALK, Conn. -- June 21-23, 2006 The Palace Hotel, San Francisco, CA

Medtech Insight, a division of Windhover Information, has announced that several high profile venture capital representatives will participate in a medical technology investment panel discussion entitled "Focus on Exit Strategy: What are the Hot Deals Now and in the Future" at its upcoming "Investment In Innovation (In3) Medical Device Summit" Conference, being held June 21-23, 2006 at The Palace Hotel in San Francisco, California. The In3 Summit (www.meddevicesummit.com), the company's largest strategic investment and partnering event for medical technology executives, will feature presentations by over 80 emerging medtech companies seeking investment and/or funding opportunities, focused into 3 Tracks (Cardio/Peripheral Vascular, Spine and Orthopedics, and Other High-Growth Technologies), a 50% larger speaker faculty than past In3 events, more VC and large/mid-size company presentations, and focused workshops for start-up companies. For the first time ever, attendees will also benefit from Medtech Insight's new Partnering Software, that allows attendees to access a wealth of searchable information on other attending companies, including detailed company and delegate profile information, a database of licensing opportunities, and the ability to communicate with and directly schedule meetings with prospective partners.

The "Focus on Exit Strategy: What are the Hot Deals Now and in the Future" panel discussion includes Trevor Moody, Frazier Healthcare Ventures, Leslie Bottorff, Medical Technology Onset Ventures, Sami Hamade, Guidant Corporation, Brent Ahrens, Canaan Ventures and Michael Carusi, Advanced Technology Ventures and will focus on the following topics: where do the ideas come from; how to capitalize on the medtech industry; why invest in certain technologies and companies; rationale behind early stage investments; and picks for deals of the year and why.

The 80+ emerging medical technology company presentations being spotlighted at the In3 Summit will each be followed by break-out sessions in private conference rooms. Track 1 (Cardiovascular and Peripheral Vascular Diagnostics and Therapeutics) presenters confirmed to date include VasoGenix Pharmaceuticals, CVAC Systems Inc., Design Medical, Percardia, Inc., Vascular Reconditioning, Inc., Edrich Health Technologies, Cardium Therapeutics, Alchimer S.A., Biophan Cardiovascular Division, Wireless 2000, Ample Medical, Inc., FlowCardia, Inc., InfraReDx, WideMed, Ltd., Unilead International, Inc., Meridian Co., Ltd. Confirmed Track 2 (Orthopedics and Spine) presenters to date include SpineVision, SA, Tibion Corporation, ISTO Technologies, Inc., VitalWear, Inc., SpineMatrix, Inc., St. Francis Medical Technologies, Conexis Biosciences, Disc Dynamics, Inc., BioniCare Medical Technologies, Inc, CoreSpine Technologies, SpinX Technologies, SA, Bone Solutions, Inc., CeraPedics, LLC, Ranier Technology, Ltd., Xylos, Vivoxid (Muller), HydroCision, Inc., Nexgen Spine, BioMedical Enterprises, Inc., and Genis. Track 3 presenters (Other High-Growth Technologies such as Drug Delivery, Gastrointestinal, General Surgery, Imaging, Metabolic Disorders, Neurology, Oncology, Ophthalmology, Tissue Engineering, and Uro/Gynecology, and Wound Management, among others) to date include GlucoLight Corporation, Vivoxid (Flaherty), CleveX LLC, Renatus, Light Sciences New Technology Group, Nanolution Technologies, Inc., StemCapture, Inc., Vision Solutions Technologies, Inc., TyRx Pharma, Inc., Universal Medical Technologies, Vitality Medical Products, Inc., Micro Medical Devices, Inc., Novashunt, Inc., CoolTouch, Inc., Biomedix, SA, VivoMedical Inc., Ogenix, BioCare Systems, Inc., Aestis, Inc., Glucon, Inc., Aperon Biosystems Corporation, EMcision, Ltd., BioImagene, Smart Holograms, Inc., Nanomix, Inc, Visionsense, Inc., Biofisica, LLC., Robin Medical, Livercyte, Ltd., and Motorika. Large Company Presentations focus on Healthlink and Aesculap.

Additional speakers participating at the In3 Summit include Tom Fogarty, Founder, Fogarty Engineering, Rich Ferrari, Managing Director, De Novo Ventures, David Douglass, General Partner, Delphi Ventures, Hanson S. Gifford, III, President and CEO, The Foundry; Hank Plain, Vice Chairman, The Foundry; Bryant Zanko, Vice President, Business Development, Stryker Corporation; Alan Will, Managing Director, Split Rock Partners; and Michael Carusi, General Partner, Advanced Technology Ventures. In addition, David Cassak, Managing Partner at Windhover Information, will give the State of the Start-up Industry Address entitled "A Market Analysis of Where Medical Technology Companies are Going." Visit the In3 Summit website at www.meddevicesummit.com for full event details.

The In3 Summit audience will represent the largest dealmakers in the worldwide medtech industry and healthcare investment community; attending companies include, among many others, 3M, Abbott Laboratories, Boston Scientific, Cardinal Health, Cook Group, Cordis, C.R. Bard, De Novo Ventures, DePuy/Johnson & Johnson, Earlybird Ventures, Edwards Lifesciences, Ethicon Endo-Surgery, Golden Gate Capital, Guidant, Hospira, Integra LifeSciences, Medtronic, Johnson & Johnson, KeyBanc Capital Markets, Kimberly-Clark, Kobayashi Pharmaceuticals of America, Krauth Medical, Lighthouse Capital Partners, Matignon Technologies FCPR, Morgan Stanley, Musculoskeletal Transplant Foundation, NASDAQ, Novartis Pharma, Olympus America, Prospect Venture Partners, Rodman & Renshaw, Rothschild, Smith & Nephew, Sorin, Stryker, The Aurora Funds, Thomas Weisel Healthcare Venture Partners, Three Arch Partners, Triathlon Medical Ventures, Terumo, Wilson Sonsini Goodrich & Rosati, and ZEVEX International.

Co-sponsors for the In3 Summit include AdvaMed, Battelle, Business Wire, Finnegan Henderson Farabow Garrett & Dunner LLP, Medical Capital Advisors, Medmarc and The Hartford, The Harvard Clinical Research Institute (HCRI), Reimbursement Principles, Ronald Trahan Associates, Teledyne Medical Microsystems, The MedTech Group, Underwriters Laboratories, Factory CRO, and Alquest, Inc.

To register, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., e-mail [e-mail], or register on the In3 Medical Device Summit website at www.meddevicesummit.com. Through April 28, 2006, attendees registering for the conference can save $100 off the $1,495 registration fee.

Medtech Insight's medical technology investment and partnering conferences have drawn over 5,850 attendees and more than 650 innovative early-stage presenting companies since their inception, making them the premier investment, partnering and networking event in the medical technology industry.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.